In a study of fruit flies, NIH scientists suggested that the body’s immune system may play a critical role in the damage caused by aging brain disorders. The results are based on experiments in which the researchers altered the activity of…
Cutting Off Melanoma’s Escape Routes
Stopping melanoma from spreading to other parts of the body might be as simple as cutting off the blood supply to cancer, according to researchers. Scientists from The University of Queensland’s Diamantina Institute have discovered stem cells that form blood vessels in…
World AIDS Day December 1, 2018
Each year on World AIDS Day, we reflect on the remarkable progress that has been made against HIV. Indeed, we have come a long way since the disease now known as AIDS was first reported in 1981. We now have life-saving…
A Cancer Drug May Help Treat Human Papillomavirus Infections
HPV infections caused an estimated 266,000 deaths from cervical cancer worldwide in 2012, according to the World Health Organization. Routine screening by Pap smears or Human Papilloma Virus DNA tests has reduced death rates in developed countries compared to less developed…
Potential Treatment for Common Soft-tissue Childhood Cancer
Scientists have developed a potential new therapeutic approach for synovial sarcoma, one of the most common soft-tissue cancers in teenagers and young adults. At present the long-term survival rates for synovial sarcoma patients is well below 50 percent; a fact that…
FDA Approves First Treatment Specifically for Patients With Rare Immune Disease
The FDA has approved Novimmune SA’s Gamifant (emapalumab) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) who have refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. This FDA approval is…
Top Clinical Research Organizations at a Glance!
Clinical Research would be a lot more difficult without the help of Clinical Research Organizations (CROs). These companies within the pharmaceutical industry not only help support drug companies but also companies in the biotechnology and medical device industries as well. Some…
A phase 3 study for chikungunya vaccine after passing midstage test
The chikungunya vaccine, known as MV-CHIK, hit its primary goal in the phase 2 trial, and Themis is now eyeing a move into phase 3. The company based its chikungunya shot on its measles vector platform, licensed from Institut Pasteur. In the…
Researchers Use Genetics to Predict Response to Antipsychotic Medications
Genetics can be used to predict a patient’s response to Antipsychotic Medications treatment for schizophrenia, according to a recent study by investigators at The Feinstein Institute for Medical Research. The findings were published online in the American Journal of Psychiatry.Schizophrenia is one…